Please note that we charge an extra fee for prenatal analysis.
Prenatal Testing Is Given the Highest Priority at CENTOGENE
Prenatal genetic testing for congenital and early onset diseases. Early and accurate identification of disease-causing mutations in "at-risk" families before birth. All monogenic diseases can be detected, even at the early stages of pregnancy.
The choice of the appropriate testing strategy and a quick response are key factors to minimize the stress.
This is why CENTOGENE offers a turnaround time of ten business days for most prenatal analyses (known variants, deletion/duplication analysis, single gene sequencing) and of less than 15 business days for NGS (next generation sequencing) analyses (CentoXome®, CentoGenome® and CentoArray®). In addition, our medical experts are always available for your support before, during and after the analysis.
- Chorionic villi
- Amniotic fluid
- Fetal DNA
- Cord blood (for late pregnancies) as possible material
You have the option to send us tubes with already cultivated cells. Alternatively, we offer CentoCulture®, our cell cultivation service.
Please always contact us prior to every prenatal sample sending to prevent transport delays and to allow us to give the analysis top priority. Please provide the following mandatory information :
- Logistics tracking number of sample shipment
- Requested analysis
- Physician's contact information
All prenatal cases are specifically assigned to our dedicated prenatal team who takes the utmost individual care.
Logistic and Communication Manager
+49 381 80113 663
For timely sample registration over the weekend, all prenatal samples must reach our laboratory no later than 3:30 p.m. CEST on Friday or 2:00 p.m. CEST on Saturday.
Proof-of-Principle Rapid Noninvasive Prenatal Diagnosis of Autosomal Recessive Founder Mutations
Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations. Ten parental alleles in eight unrelated fetuses were diagnosed successfully based on the noninvasive […]
Validation of a Semiconductor Next-Generation Sequencing Assay for the Clinical Genetic Screening of CFTR
Genetic testing for cystic fibrosis and CFTR-related disorders mostly relies on laborious molecular tools that use Sanger sequencing to scan for mutations in the CFTR gene. We have explored a more […]
A Novel Mutation Causing 17-β-Hydroxysteroid
This is the first case report in Oman and the Gulf region of a 17-β-hydroxysteroid dehydrogenase type 3 (17-β-HSD3) deficiency with a novel mutation in the HSD17B3 gene that has not been previously […]
Illumina and CENTOGENE: Using NIPT to Screen for the Most Common Fetal Chromosomal Abnormalities
Everybody is talking about it: Non-invasive prenatal testing (NIPT) to screen for the most common fetal chromosomal abnormalities. With CentoNIPT® CENTOGENE now offers non-invasive prenatal testing […]